ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Specialist

Top Specialist Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FAUSTO GONZALEZ MD

Specialist

29,307

$2.55M

860
567 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 33%

$87
Average prescription price

Avg: $112

BENJAMIN WU

Specialist

24,830

$2.7M

511
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 33%

$109
Average prescription price

Avg: $112

JON MICHNOVICZ M.D.

Specialist

20,974

$1.16M

832
101 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 33%

$55
Average prescription price

Avg: $112

HAN CHANG MD

Specialist

17,799

$939K

473
396 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 33%

$53
Average prescription price

Avg: $112

ZAFER ALI M.D.

Specialist

16,306

$892K

427
384 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 33%

$55
Average prescription price

Avg: $112

SUMATHY REDDY M.D., F.A.A.F.P.

Specialist

13,509

$857K

345
264 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 33%

$63
Average prescription price

Avg: $112

MAYRA MAHADIN M.D.

Specialist

12,514

$894K

373
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 33%

$71
Average prescription price

Avg: $112

KEVORK BOYADJIAN MD

Specialist

12,379

$596K

466
441 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 33%

$48
Average prescription price

Avg: $112

BELINDA VELAZQUEZ M.D.

Specialist

12,257

$1.2M

380
293 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 33%

$98
Average prescription price

Avg: $112

ROBERT MOSKOWITZ MD FACP

Specialist

12,187

$824K

511
479 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 33%

$68
Average prescription price

Avg: $112

GABRIEL GUSTIN M.D

Specialist

12,075

$851K

380
307 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 33%

$70
Average prescription price

Avg: $112

VALERY KUZNETSOV M.D.

Specialist

11,313

$884K

669
645 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 33%

$78
Average prescription price

Avg: $112

DEAN CHASKY M.D.

Specialist

11,055

$688K

497
436 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 33%

$62
Average prescription price

Avg: $112

MYAT SAN M.D.

Specialist

10,683

$728K

558
389 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 33%

$68
Average prescription price

Avg: $112

RAZA MAMDANI M.D.

Specialist

10,525

$698K

533
388 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 33%

$66
Average prescription price

Avg: $112

MUMTAZ KARIMI MD

Specialist

10,277

$468K

393
210 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 33%

$46
Average prescription price

Avg: $112

MIRON FAYNGERSH MD

Specialist

9,269

$1.04M

539
463 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 33%

$112
Average prescription price

Avg: $112

PETER ROSENBERG MD

Specialist

9,072

$527K

762
714 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 33%

$58
Average prescription price

Avg: $112

SHEFALI PATEL MD

Specialist

8,869

$461K

403
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 33%

$52
Average prescription price

Avg: $112

MICHAEL AMOASHIY MD

Specialist

8,863

$1.28M

860
706 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 33%

$144
Average prescription price

Avg: $112

JIAN CUI M.D.

Specialist

8,672

$581K

1556
1415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 33%

$67
Average prescription price

Avg: $112

JOHN SAURET MD

Specialist

8,601

$468K

502
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 33%

$54
Average prescription price

Avg: $112

VIRAL SHETH MD

Specialist

8,591

$983K

739
635 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 33%

$114
Average prescription price

Avg: $112

YVES LAFOND M.D.

Specialist

8,578

$457K

350
311 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 33%

$53
Average prescription price

Avg: $112

BIJAN GOLYAN

Specialist

8,363

$516K

426
384 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 33%

$62
Average prescription price

Avg: $112

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank